edoc

Evaluation of a novel micro-sampling device, Mitratm, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural Côte d'Ivoire

Kovač, Jana and Panic, Gordana and Neodo, Anna and Meister, Isabel and Coulibaly, Jean T. and Schulz, Jessica D. and Keiser, Jennifer. (2018) Evaluation of a novel micro-sampling device, Mitratm, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural Côte d'Ivoire. Journal of Pharmaceutical and Biomedical Analysis, 151. pp. 339-346.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/65194/

Downloads: Statistics Overview

Abstract

Pharmacokinetic (PK) studies with paediatric populations are increasing in importance for drug development. However, conventional PK sampling methods are characterised by invasiveness and low patient adherence, unsuitable for use with sensitive population, such as children. Mitratm is a novel volumetric absorptive micro-sampling device, which offers an alternative to the dried blood spotting (DBS) technique, a current popular sampling technique within PK studies. We tested Mitratm for the first time in the framework of a randomised controlled trial in rural Côte d'Ivoire. Thirty-five school-aged children, infected with Schistosoma haematobium, were sampled with both DBS and Mitratm, at 10 time points after treatment with praziquantel (PZQ). An extraction method for PZQ from Mitratm was developed, optimised and validated. Analytes, namely R- and S-praziquantel (R-/SPZQ) and the main human metabolite, R-trans-4-OH-praziquantel, were measured using liquid chromatography-tandem mass spectrometry and the results were compared with Bland-Altman analysis to determine agreement between matrices. PK parameters, such as maximal plasma concentration and area under the concentration-time curve, were estimated using non-compartmental analysis. While we observed strong positive correlation (R; 2; > 0.98) and agreement between both matrices within the calibration line and quality control samples, Mitratm revealed higher concentrations of all the analytes in the majority of patients' samples compared to DBS sampling, namely 63% samples for RPZQ, 49% for SPZQ and 78% for the metabolite were overestimated. While T; 1/2; and Tmax were in agreement between both matrices, area under the curve and maximal blood concentration were up to 2× higher for Mitratm samples, with P < 0.005 for all parameters except C; max; of SPZQ, which was not significantly different between the two matrices. The reasons for the higher PZQ concentrations, more pronounced in incurred Mitratm samples compared to spiked samples, are yet to be fully explored. Mitratm appears superior to DBS in terms of simplicity and practicality however labelling issues and the high price of Mitratm are difficult to overlook.
Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH)
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology > Helminth Drug Development (Keiser)
UniBasel Contributors:Kovac, Jana and Panic, Gordana and Meister, Isabel and Keiser, Jennifer
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Elsevier
ISSN:0731-7085
e-ISSN:1873-264X
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:11 Sep 2018 07:31
Deposited On:11 Sep 2018 07:31

Repository Staff Only: item control page